The CMC section of the drug regulatory submission mirrors the output of your Criticality Analysis. The Pharmaceutical Quality Risk Assessment provides a risk-based control strategy which forms the basis of the CMC section. When it comes to deploying quality risk management in the pharmaceutical industry, you cannot beat our data and risk-based approach to presenting the CMC control strategy.

свернуть